These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34299526)

  • 21. NMR spectroscopy as a characterization tool enabling biologics formulation development.
    Ma J; Pathirana C; Liu DQ; Miller SA
    J Pharm Biomed Anal; 2023 Jan; 223():115110. PubMed ID: 36308923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the Higher-Order Structure of Formulated Monoclonal Antibody Therapeutics by 2D Methyl Correlated NMR and Principal Component Analysis.
    Arbogast LW; Delaglio F; Brinson RG; Marino JP
    Curr Protoc Protein Sci; 2020 Jun; 100(1):e105. PubMed ID: 32407007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NMR profiling of biomolecules at natural abundance using 2D 1H-15N and 1H-13C multiplicity-separated (MS) HSQC spectra.
    Chen K; Freedberg DI; Keire DA
    J Magn Reson; 2015 Feb; 251():65-70. PubMed ID: 25562571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multivariate Analysis of Two-Dimensional
    Arbogast LW; Delaglio F; Schiel JE; Marino JP
    Anal Chem; 2017 Nov; 89(21):11839-11845. PubMed ID: 28937210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Calcitonin Salmon Nasal Spray: similarity of peptide formulated in chlorobutanol compared to benzalkonium chloride as preservative.
    Costantino HR; Culley H; Chen L; Morris D; Houston M; Roth S; Phoenix MJ; Foerder C; Philo JS; Arakawa T; Eidenschink L; Andersen NH; Brandt G; Quay SC
    J Pharm Sci; 2009 Oct; 98(10):3691-706. PubMed ID: 19226627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HET-SOFAST NMR for fast detection of structural compactness and heterogeneity along polypeptide chains.
    Schanda P; Forge V; Brutscher B
    Magn Reson Chem; 2006 Jul; 44 Spec No():S177-84. PubMed ID: 16823898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of methyl 13C-15N dipolar couplings in peptides and proteins by three-dimensional and four-dimensional magic-angle spinning solid-state NMR spectroscopy.
    Helmus JJ; Nadaud PS; Höfer N; Jaroniec CP
    J Chem Phys; 2008 Feb; 128(5):052314. PubMed ID: 18266431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NMR investigations of structural and dynamics features of natively unstructured drug peptide - salmon calcitonin: implication to rational design of potent sCT analogs.
    Rawat A; Kumar D
    J Pept Sci; 2013 Jan; 19(1):33-45. PubMed ID: 23208874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3D J-resolved NMR spectroscopy for unstructured polypeptides: fast measurement of 3J HNH alpha coupling constants with outstanding spectral resolution.
    Lendel C; Damberg P
    J Biomol NMR; 2009 May; 44(1):35-42. PubMed ID: 19330299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective detection of active pharmaceutical ingredients in tablet formulations using solid-state NMR spectroscopy.
    Hong YL; Manjunatha Reddy GN; Nishiyama Y
    Solid State Nucl Magn Reson; 2020 Apr; 106():101651. PubMed ID: 32058901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective suppression of excipient signals in 2D
    Arbogast LW; Delaglio F; Tolman JR; Marino JP
    J Biomol NMR; 2018 Dec; 72(3-4):149-161. PubMed ID: 30483914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physicochemical and functional assessments demonstrating analytical similarity between rituximab biosimilar HLX01 and the MabThera®.
    Xu Y; Xie L; Zhang E; Gao W; Wang L; Cao Y; Xie MH; Jiang W; Liu S
    MAbs; 2019 Apr; 11(3):606-620. PubMed ID: 30794092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct Assessment of Oligomerization of Chemically Modified Peptides and Proteins in Formulations using DLS and DOSY-NMR.
    Wang K; Chen K
    Pharm Res; 2023 Jun; 40(6):1329-1339. PubMed ID: 36627448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics.
    Brinson RG; Marino JP; Delaglio F; Arbogast LW; Evans RM; Kearsley A; Gingras G; Ghasriani H; Aubin Y; Pierens GK; Jia X; Mobli M; Grant HG; Keizer DW; Schweimer K; Ståhle J; Widmalm G; Zartler ER; Lawrence CW; Reardon PN; Cort JR; Xu P; Ni F; Yanaka S; Kato K; Parnham SR; Tsao D; Blomgren A; Rundlöf T; Trieloff N; Schmieder P; Ross A; Skidmore K; Chen K; Keire D; Freedberg DI; Suter-Stahel T; Wider G; Ilc G; Plavec J; Bradley SA; Baldisseri DM; Sforça ML; Zeri ACM; Wei JY; Szabo CM; Amezcua CA; Jordan JB; Wikström M
    MAbs; 2019 Jan; 11(1):94-105. PubMed ID: 30570405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Comparison Between Emerging and Current Biophysical Methods for the Assessment of Higher-Order Structure of Biopharmaceuticals.
    Wen J; Batabyal D; Knutson N; Lord H; Wikström M
    J Pharm Sci; 2020 Jan; 109(1):247-253. PubMed ID: 31669605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sedimentation Velocity Analytical Ultracentrifugation Analysis of Marketed Rituximab Drug Product Size Distribution.
    Patil SM; Nguyen J; Keire DA; Chen K
    Pharm Res; 2020 Nov; 37(12):238. PubMed ID: 33155155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of structural and functional similarity of biosimilar products: Rituximab as a case study.
    Nupur N; Chhabra N; Dash R; Rathore AS
    MAbs; 2018 Jan; 10(1):143-158. PubMed ID: 29200314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined Liquid-State and Solid-State Nuclear Magnetic Resonance at Natural Abundance for Comparative Higher Order Structure Assessment in the Formulated-State of Biphasic Biopharmaceutics.
    Pujahari SR; Mali PS; Purusottam RN; Kumar A
    Anal Chem; 2023 Jun; 95(22):8469-8477. PubMed ID: 37154614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemometric Outlier Classification of 2D-NMR Spectra to Enable Higher Order Structure Characterization of Protein Therapeutics.
    Sheen DA; Shen VK; Brinson RG; Arbogast LW; Marino JP; Delaglio F
    Chemometr Intell Lab Syst; 2020; 199():. PubMed ID: 34135539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.